Chemours Company [CC] stock is trading at $11.52, up 2.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The CC shares have gain 9.40% over the last week, with a monthly amount drifted -20.00%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Chemours Company [NYSE: CC] stock has seen the most recent analyst activity on March 27, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $19 for it. Previously, Truist started tracking the stock with Buy rating on January 28, 2025, and set its price target to $27. On July 09, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $30 on the stock. Mizuho started tracking the stock assigning a Neutral rating and suggested a price target of $25 on June 07, 2024. BMO Capital Markets upgraded its rating to a Outperform and raised its price target to $34 on April 09, 2024. UBS downgraded its rating to Neutral for this stock on March 05, 2024, and downed its price target to $21. In a note dated February 29, 2024, BMO Capital Markets downgraded an Underperform rating on this stock and revised its target price from $45 to $19.
Chemours Company [CC] stock has fluctuated between $9.33 and $29.21 over the past year. Currently, Wall Street analysts expect the stock to reach $30.33 within the next 12 months. Chemours Company [NYSE: CC] shares were valued at $11.52 at the most recent close of the market. An investor can expect a potential return of 163.28% based on the average CC price forecast.
Analyzing the CC fundamentals
Chemours Company [NYSE:CC] reported sales of 5.78B for the trailing twelve months, which represents a growth of 2.42%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.13 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of7.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.26 points at the first support level, and at 11.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.74, and for the 2nd resistance point, it is at 11.96.
Ratios To Look Out For
For context, Chemours Company’s Current Ratio is 1.68. On the other hand, the Quick Ratio is 0.86, and the Cash Ratio is 0.4. Considering the valuation of this stock, the price to sales ratio is 0.30, the price to book ratio is 2.85 and price to earnings (TTM) ratio is 19.89.
Transactions by insiders
Recent insider trading involved Scarborough Alvenia, SVP Corp Communications & CBO, that happened on Nov 07 ’24 when 7500.0 shares were sold. Officer, Scarborough Alvenia completed a deal on Nov 06 ’24 to buy 7500.0 shares. Meanwhile, Interim Pres. – Titanium Tech Picho Diane I. sold 2684.0 shares on Aug 07 ’24.
